Skip to content
  • For Healthcare Professionals
Muscular Dystrophy News logo
Newsletter
  • For Healthcare Professionals
  • About MD
    Muscular dystrophy overview
    • Causes
    • Symptoms
    • Diagnosis
    • Life expectancy
    Treatments
    • Approved treatments
    • Experimental treatments
    • Non-drug treatments
    Types
    • Becker muscular dystrophy
    • Bethlem myopathy
    • Congenital muscular dystrophies
    • Duchenne muscular dystrophy
    • Facioscapulohumeral muscular dystrophy
    • Limb-girdle muscular dystrophy
    • Myotonic dystrophy
    • Tibial muscular dystrophy
  • Living with
    Living with muscular dystrophy
    Exercise and physiotherapy
    Diet
    Breathing difficulties
    Heart problems
    Joint care
    Support and resources
    Assistive technology
    Speech therapy
  • Community
    Perspectives
    • Duchenne: Shalom’s Lifelong Partner-in-Crime — Shalom Lim Ern Rong
    • Muscle Memoirs: LGMD Experiences — Patrick Moeschen
    • Party of 9 — Betty Vertin
    • Working Through the Process — Robin Stemple
    More Perspectives
    • Bloom – Prudence Jones
    • Hawk’s-Eye View – Hawken Miller
    • Hidden Truths – Adeel Rizvi
    • Of Dragons and Dystrophin – Andy Rusch
    Guest Voices
  • News
  • Forums
  • Resources
    Video & Podcasts
    • Treatment risks and uncertainty
    • Setting boundaries with caregivers
    • Overcoming discomfort
    • Finding motivation
    • Mental health support
    Featured Topics
    • Caregiver’s guide to DMD
    • Adaptive living
    • Navigating DMD
    Advocacy partners
    Clinical & Scientific Conference Coverage

The major turning point in Duchenne progression

Cardiac disease

Gowers’ maneuver

Early clues

See more videos

Daniel Guillen, MD, discusses one of the most significant milestones in DMD: the loss of ambulation. Learn why this transition marks a major inflection point in disease progression and how it relates to respiratory function, heart health, and long-term outcomes.

What marks the major inflection point in the DMD disease trajectory?

Transcript

I think there are a couple of spots in which this becomes important. A handful.

Read More

Probably the one that families remember most clearly is when their children lose ambulation, the ability to walk. And that tends to happen historically between 8 to 10 years of age. But with current treatments and current data, it seems to be in the 12-year age range.

However, I would say with our newest treatments, we’re seeing some of these treatments push the ability to walk into later teenage years, depending on what combination of therapies we’re using and their newest data.

It seems like that’s going to be longer, but the loss of the ability to walk is a big inflection point for a couple of reasons. One is when the degree of weakness is to that level, then the breathing muscles start getting affected. Then we need to monitor more carefully into loss of strength when breathing. Brace for pneumonia.

When we’re approaching the loss of ability to walk, we start seeing more falls. And that can lead to fractures. And then around that age, definitely by 10 years of age or so, and even older, that’s when we start seeing more clear heart muscle disease, cardiomyopathy.

Unfortunately for Duchenne muscular dystrophy, the majority of boys passing away nowadays are not passing away because of this muscle weakness, but more so because of the heart disease and respiratory weakness.

And then the other point to think about is when they start declining for the first time, there is weakness. And there has been muscle rupture ever since prior to being born. But sometime in between 7 to 10 years of age, they were getting stronger year over year.

And then you start noticing them getting weaker year over year. And then you know that the loss of ability to walk is going to come within a few years from that.

Early clues that can point to Duchenne
The Gowers’ maneuver in Duchenne
See more videos

  Subscribe to our newsletter

Get regular updates to your inbox.

This field is for validation purposes and should be left unchanged.

Bionews Logo Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • Muscular Dystrophy News on Facebook
  • Muscular Dystrophy News on X
  • Muscular Dystrophy News on Instagram
  • Muscular Dystrophy News on Pinterest
  • About Us
    • Our Culture
    • Leadership
    • Careers
    • Contact Us
  • Explore More
    • Advertising Policy
    • Corrections Policy
    • Editorial Policy
    • Privacy Policy
    • Terms of Service
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2026 All rights reserved.

Log in

Don't have an account?

Log in

[wppb-login register_url="/register" lostpassword_url="/recover-password" ajax=true]

|

Register

Already have an account?

Register

Create your account by filling in the information below:

[wppb-register redirect_url="/welcome" ajax=true]

By creating an account, you are agreeing to the Privacy Policy and Terms of Service.

Reset Password

[wppb-recover-password ajax=true]